← All peptidesBlends
Tesamorelin + Ipamorelin
Tesamorelin + Ipamorelin
GHRH analog plus ghrelin agonist, researched for visceral-fat reduction and body recomposition via the GH/IGF-1 axis.
Typical dose
1–2 mg
Frequency
Nightly (often 5-on / 2-off)
Half-life
—
Route
subcutaneous
Typical vial sizes
10 mg13 mg
Sample reconstitution
10 mg vial · 2 mL bac water · 1.5 mg dose
- Draw volume
- 0.300 mL
- Insulin units
- 30 units
- Concentration
- 5.00 mg/mL
- Doses per vial
- 6.7
Research notes
As sold: Tesamorelin 10mg + Ipamorelin 3mg (also 5mg+5mg). ~1mg tesamorelin + 300mcg ipamorelin nightly is a common protocol.
Further reading
- Published research on Tesamorelin + Ipamorelin (PubMed) →
- Clinical trials for Tesamorelin + Ipamorelin (ClinicalTrials.gov) →
Links open live searches on authoritative databases — verify dosing and safety against primary sources.
Research use only.
Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.